On April 6, HealthEquity (HQY) announced that the employment of Eli Rosner, the Company’s Chief Technology Officer, will be terminated by the Company without cause, effective April 17, 2026. Sunil Rajasekar, the Company’s Executive Vice President, Chief Product and Strategy Officer, will be responsible for overseeing the Company’s technology organization as of that date.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HQY:
- HealthEquity Adds Sanford Health CEO Bill Gassen to Board
- HealthEquity price target raised to $128 from $120 at Deutsche Bank
- HealthEquity Inc. Earnings Call Highlights Profitable Growth
- HealthEquity: Strong Operational Execution and HSA Market Leadership Support Buy Rating and Upside to $110 Target
- HealthEquity price target lowered to $110 from $125 at Barrington